Intensity Therapeutics logo

Intensity Therapeutics

INTS | NASDAQ
Chart Builder DCF Calculator
$3.07
-$0.01 (-0.32%)
At close: Nov 16, 2026, 4:00 PM ET
$3.07
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-0.32%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #605/1021 (Top 59%)

Key Statistics

Market Data

Market Cap $10M
1D Range
3.00 3.08
52W Range
3.00 14.75

Valuation (TTM)

PE -0.70
PB 1.31
EV/EBITDA -0.13

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $11.00
Loading financial charts...

Profile

Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Jun 30, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$11.00
Upside
+258.31%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.